Table 1.
Demographic, clinical, laboratory, and cardiovascular disease-related characteristics in patients with axial spondyloarthritis
| Variable | axSpA (n = 510) |
|---|---|
| Men/women, n | 360/150 |
| Age (years), mean ± SD | 48.8 ± 12.4 |
| Age at axSpA diagnosis (years), mean ± SD | 35.8 ± 11.4 |
| C-reactive protein (mg/L), mean ± SD | 5.7 ± 9.8 |
| Erythrocyte sedimentation rate (mm/1st hour), mean ± SD | 10.9 ± 16.2 |
| Bath Ankylosing Spondylitis Disease Activity Index, mean ± SD | 3.7 ± 2.3 |
| Ankylosing Spondylitis Disease Activity Score, mean ± SD | 2.2 ± 1.0 |
| Bath Ankylosing Spondylitis Functional Index, mean ± SD | 3.4 ± 2.6 |
| HLA-B27 status, % | 78.0 |
| Peripheral synovitis, % | 37.7 |
| Hip involvement, % | 20.4 |
| Enthesitis, % | 29.2 |
| Extra-articular manifestations*, % | 36.5 |
| Syndesmophytes, % | 43.5 |
| History of classic cardiovascular risk factors, % | |
| Smoking | 52.0 |
| Obesity | 22.4 |
| Dyslipidemia | 32.0 |
| Hypertension | 26.6 |
| Body mass index (kg/m2), mean ± SD | 27.2 ± 5.0 |
| Systolic blood pressure (mm Hg), mean ± SD | 129.1 ± 17.6 |
| Diastolic blood pressure (mm Hg), mean ± SD | 80.3 ± 11.2 |
| Total cholesterol (mg/dL), mean ± SD | 191.2 ± 39.4 |
| HDL-cholesterol (mg/dL), mean ± SD | 54.2 ± 16.5 |
| LDL-cholesterol (mg/dL), mean ± SD | 115.4 ± 32.6 |
| Triglycerides (mg/dL), mean ± SD | 122.7 ± 79.2 |
| Atherogenic index (total cholesterol/HDL), mean ± SD | 3.8 ± 1.2 |
| Atherogenic index ≥4, % | 36.5 |
| Carotid IMT (mm), mean ± SD | 0.646 ± 0.144 |
| Carotid plaques, % | 28.8 |
axSpA axial spondyloarthritis, HDL high-density lipoprotein, IMT intima-media thickness, LDL low-density lipoprotein, SD standard deviation. *Including anterior uveitis, psoriasis, and/or inflammatory bowel disease
Data shown in this table refer to values at the time of the study